Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea Syndromes | 12 | 2023 | 28 | 6.840 |
Why?
|
| Sleep Apnea, Obstructive | 13 | 2024 | 55 | 6.640 |
Why?
|
| Continuous Positive Airway Pressure | 9 | 2025 | 32 | 2.750 |
Why?
|
| Sleep Apnea, Central | 4 | 2025 | 7 | 2.650 |
Why?
|
| Polysomnography | 6 | 2025 | 57 | 1.560 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 2020 | 33 | 1.270 |
Why?
|
| Corpus Striatum | 2 | 2020 | 96 | 1.230 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2025 | 57 | 1.100 |
Why?
|
| Hypoventilation | 2 | 2022 | 4 | 0.980 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2015 | 12 | 0.950 |
Why?
|
| Physicians | 2 | 2021 | 464 | 0.900 |
Why?
|
| Ischemic Attack, Transient | 2 | 2018 | 96 | 0.870 |
Why?
|
| Sleep Wake Disorders | 2 | 2025 | 69 | 0.870 |
Why?
|
| Time | 1 | 2023 | 30 | 0.850 |
Why?
|
| Sleep | 6 | 2025 | 226 | 0.840 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2023 | 4 | 0.820 |
Why?
|
| Motor Disorders | 1 | 2023 | 4 | 0.820 |
Why?
|
| Parasomnias | 1 | 2023 | 2 | 0.820 |
Why?
|
| Restless Legs Syndrome | 1 | 2023 | 8 | 0.810 |
Why?
|
| Postal Service | 1 | 2022 | 6 | 0.790 |
Why?
|
| Laboratories, Hospital | 1 | 2022 | 10 | 0.780 |
Why?
|
| Schools | 1 | 2023 | 159 | 0.770 |
Why?
|
| Research Design | 2 | 2015 | 573 | 0.740 |
Why?
|
| Health Policy | 1 | 2023 | 189 | 0.740 |
Why?
|
| Humans | 36 | 2025 | 62865 | 0.720 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 381 | 0.670 |
Why?
|
| Telemedicine | 2 | 2025 | 318 | 0.660 |
Why?
|
| Glutamic Acid | 2 | 2019 | 98 | 0.640 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2019 | 17 | 0.630 |
Why?
|
| Cooperative Behavior | 3 | 2017 | 221 | 0.630 |
Why?
|
| Alcohol-Related Disorders | 1 | 2019 | 38 | 0.620 |
Why?
|
| Snoring | 1 | 2018 | 8 | 0.620 |
Why?
|
| Positive-Pressure Respiration | 2 | 2012 | 48 | 0.610 |
Why?
|
| Health Services Research | 3 | 2024 | 270 | 0.600 |
Why?
|
| Respiratory System | 1 | 2018 | 45 | 0.600 |
Why?
|
| Synaptic Transmission | 1 | 2019 | 150 | 0.580 |
Why?
|
| Stroke | 3 | 2018 | 1190 | 0.560 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2016 | 3 | 0.530 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 314 | 0.520 |
Why?
|
| Ethanol | 1 | 2019 | 321 | 0.500 |
Why?
|
| Respiration, Artificial | 3 | 2014 | 295 | 0.490 |
Why?
|
| Delivery of Health Care | 3 | 2015 | 432 | 0.450 |
Why?
|
| Medical Informatics | 1 | 2014 | 72 | 0.440 |
Why?
|
| Research | 1 | 2014 | 192 | 0.410 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 331 | 0.390 |
Why?
|
| Headache | 1 | 2012 | 58 | 0.390 |
Why?
|
| Ventilator Weaning | 1 | 2012 | 20 | 0.380 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 154 | 0.320 |
Why?
|
| Male | 12 | 2022 | 29552 | 0.290 |
Why?
|
| Female | 11 | 2025 | 32566 | 0.280 |
Why?
|
| United States | 9 | 2025 | 7744 | 0.270 |
Why?
|
| Pandemics | 2 | 2021 | 664 | 0.250 |
Why?
|
| Public Opinion | 1 | 2025 | 24 | 0.240 |
Why?
|
| Policy Making | 1 | 2025 | 47 | 0.240 |
Why?
|
| Sleep Medicine Specialty | 1 | 2025 | 3 | 0.240 |
Why?
|
| Retrospective Studies | 5 | 2022 | 6545 | 0.240 |
Why?
|
| Neurologists | 1 | 2023 | 7 | 0.210 |
Why?
|
| Seasons | 1 | 2024 | 133 | 0.210 |
Why?
|
| Body Mass Index | 2 | 2020 | 864 | 0.210 |
Why?
|
| Hot Temperature | 1 | 2023 | 130 | 0.200 |
Why?
|
| Aged | 5 | 2025 | 14268 | 0.190 |
Why?
|
| Aftercare | 1 | 2022 | 75 | 0.190 |
Why?
|
| Middle Aged | 6 | 2022 | 17391 | 0.180 |
Why?
|
| Inpatients | 2 | 2014 | 302 | 0.180 |
Why?
|
| Respiration | 1 | 2022 | 89 | 0.180 |
Why?
|
| Pneumonia | 2 | 2014 | 288 | 0.180 |
Why?
|
| Medicare | 2 | 2024 | 614 | 0.170 |
Why?
|
| Hypoxia | 1 | 2021 | 113 | 0.170 |
Why?
|
| Noninvasive Ventilation | 1 | 2021 | 70 | 0.170 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2020 | 4 | 0.170 |
Why?
|
| Thalamus | 1 | 2020 | 66 | 0.160 |
Why?
|
| Hospitals | 1 | 2022 | 393 | 0.160 |
Why?
|
| Arousal | 1 | 2018 | 42 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2022 | 505 | 0.150 |
Why?
|
| Adult | 4 | 2021 | 16672 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2022 | 429 | 0.140 |
Why?
|
| Algorithms | 1 | 2023 | 1003 | 0.140 |
Why?
|
| Interdisciplinary Placement | 1 | 2017 | 2 | 0.140 |
Why?
|
| Lung | 1 | 2022 | 939 | 0.130 |
Why?
|
| Quality of Life | 1 | 2024 | 1221 | 0.130 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2015 | 9 | 0.120 |
Why?
|
| Age Factors | 1 | 2019 | 1556 | 0.120 |
Why?
|
| Education, Medical | 1 | 2017 | 182 | 0.120 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 87 | 0.110 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 116 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2019 | 2105 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 476 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1640 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2652 | 0.100 |
Why?
|
| Animals | 3 | 2020 | 20620 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 302 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 120 | 0.100 |
Why?
|
| Models, Theoretical | 1 | 2014 | 271 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 252 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 3389 | 0.090 |
Why?
|
| Time Factors | 1 | 2019 | 3749 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 337 | 0.090 |
Why?
|
| Comorbidity | 2 | 2014 | 1119 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 749 | 0.090 |
Why?
|
| Prevalence | 2 | 2014 | 1363 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2010 | 252 | 0.080 |
Why?
|
| Sex Factors | 1 | 2012 | 975 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1252 | 0.080 |
Why?
|
| Heart Failure | 1 | 2016 | 901 | 0.070 |
Why?
|
| Recurrence | 1 | 2010 | 636 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2014 | 685 | 0.070 |
Why?
|
| Mice | 1 | 2020 | 10819 | 0.060 |
Why?
|
| Respiration Disorders | 1 | 2005 | 25 | 0.060 |
Why?
|
| Oximetry | 1 | 2005 | 48 | 0.060 |
Why?
|
| Academies and Institutes | 1 | 2025 | 22 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2005 | 147 | 0.060 |
Why?
|
| Oxygen | 1 | 2005 | 316 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2025 | 366 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5596 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 1159 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 109 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 730 | 0.040 |
Why?
|
| Patient Selection | 1 | 2021 | 482 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2015 | 69 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 486 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 622 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 104 | 0.030 |
Why?
|
| Hippocampus | 1 | 2015 | 267 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 618 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2014 | 196 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 234 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 481 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 405 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 805 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2014 | 867 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2444 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 3027 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 5309 | 0.010 |
Why?
|